{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:29:43Z","timestamp":1761283783164,"version":"build-2065373602"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is interrelated with obesity. Lifestyle intervention, mainly focusing on weight loss, has emerged as promising strategies to improve fertility outcomes in women with obesity. Acupuncture can aid in weight loss through metabolic regulation. However, evaluating the effectiveness of lifestyle and acupuncture in improving symptoms of polycystic ovary syndrome is still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study aims to evaluate the efficacy of long-term lifestyle and acupuncture treatment on PCOS and elucidate the lipidomic features of these interventions in patients with overweight\/obese PCOS, and identify potential therapeutic targets. Thirty-one women with PCOS and twenty-eight age and BMI matched controls were recruited. The participants with PCOS were randomly assigned to either lifestyle and acupuncture intervention group (A&amp;amp;L) or Lifestyle and sham acupuncture group (SA&amp;amp;L) for 4\u202fmonths. The patients were followed up for an additional 4\u202fmonths. Clinical indices indicating hyperandrogenism, homeostasis and quality of life was collected to evaluate the effectiveness of treatments. Comprehensive lipidomic analyses by utilizing mass spectrometry were conducted to profile the lipidomic signatures of participants with PCOS before and after treatment. After the A&amp;amp;L intervention, the BMI of participants with PCOS was significantly reduced. Assessments of insulin resistance (HbA1c, HOMA-IR, ISI), hyperandrogenism (SHBG, FAI), physical activity, and\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -endorphin showed significant improvement. Lipidomic analysis revealed a panel of lipid species that effectively distinguished participants with PCOS from those without PCOS (AUC\u202f=\u202f0.9747). Serum 18:0 Lyso PI, involved in intracellular insulin signaling pathways, was specifically associated with the A&amp;amp;L regimen. The co-regulation of 18:0 Lyso PI and 16:0 SM (d18:1\/16:0) were associated with the A&amp;amp;L regimen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>18:0 Lyso PI may be a potential biomarker for A&amp;amp;L therapy in PCOS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1642095","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:26:34Z","timestamp":1761283594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical symptom improvement and lipidomic signatures in overweight\/obese PCOS treated by lifestyle and acupuncture intervention"],"prefix":"10.3389","volume":"12","author":[{"given":"Haolin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ii","family":"Fukuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS9518","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/life12020308","article-title":"Effectiveness of lifestyle modification in polycystic ovary syndrome patients with obesity: a systematic review and Meta-analysis","volume":"12","author":"Kim","year":"2022","journal-title":"Life (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000345310","article-title":"Development of obesity and polycystic ovary syndrome in adolescents","volume":"78","author":"Vilmann","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bcpt.12874","article-title":"The pharmacogenetics of metformin in women with polycystic ovary syndrome: a randomized trial","volume":"122","author":"Pedersen","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3831\/KPI.2021.24.4.173","article-title":"Study of latest trend on acupuncture for obesity treatment","volume":"24","author":"Chun","year":"2021","journal-title":"J Pharmacopuncture"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/obr.12747","article-title":"Effect of acupuncture and intervention types on weight loss: a systematic review and meta-analysis","volume":"19","author":"Kim","year":"2018","journal-title":"Obes Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1207574","DOI":"10.3389\/fendo.2023.1207574","article-title":"Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota","volume":"14","author":"Ding","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.13703\/j.0255-2930.20191231-k0005","article-title":"Acupuncture ameliorates negative emotion in PCOS patients: a randomized controlled trial","volume":"40","author":"Zhang","year":"2020","journal-title":"Zhongguo Zhen Jiu"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/REP-15-0542","article-title":"High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS","volume":"151","author":"Zhang","year":"2016","journal-title":"Reproduction"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1085656","DOI":"10.3389\/fendo.2022.1085656","article-title":"Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1035929","DOI":"10.3389\/fendo.2022.1035929","article-title":"Underlying mechanisms of acupuncture therapy on polycystic ovary syndrome: evidences from animal and clinical studies","volume":"13","author":"Ye","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/mnfr.201200808","article-title":"Nutritional lipidomics: molecular metabolism, analytics, and diagnostics","volume":"57","author":"Smilowitz","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/mmr.2018.9643","article-title":"UPLC\/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome","volume":"19","author":"Fan","year":"2019","journal-title":"Mol Med Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12920-021-01058-y","article-title":"Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome","volume":"14","author":"Yu","year":"2021","journal-title":"BMC Med Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum Reprod Update"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/s41598-019-52263-w","article-title":"Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women","volume":"9","author":"Pradas","year":"2019","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.2196\/jmir.6972","article-title":"Web-based interventions for weight loss or weight loss maintenance in overweight and obese people: a systematic review of systematic reviews","volume":"19","author":"Sorgente","year":"2017","journal-title":"J Med Internet Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e024733","DOI":"10.1136\/bmjopen-2018-024733","article-title":"Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial","volume":"9","author":"Stener-Victorin","year":"2019","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/jama.2017.7217","article-title":"Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial","volume":"317","author":"Wu","year":"2017","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/09513590600604541","article-title":"Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the polycystic ovary syndrome questionnaire (PCOSQ) and the short Form-36 (SF-36)","volume":"22","author":"Coffey","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1001\/jama.2017.7217","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/humrep\/dew348","article-title":"Weight management practices associated with PCOS and their relationships with diet and physical activity","volume":"32","author":"Moran","year":"2017","journal-title":"Hum Reprod"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/postgradmedj-2019-137221","article-title":"Acupuncture versus sham acupuncture for simple obesity: a systematic review and meta-analysis","volume":"96","author":"Zhong","year":"2020","journal-title":"Postgrad Med J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/humrep\/deab272","article-title":"Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial","volume":"37","author":"Wen","year":"2022","journal-title":"Hum Reprod"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.ajhg.2024.10.008","article-title":"Proteome-wide Mendelian randomization and functional studies uncover therapeutic targets for polycystic ovarian syndrome","volume":"111","author":"Ni","year":"2024","journal-title":"Am J Hum Genet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3892\/ijmm.2020.4522","article-title":"Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome","volume":"45","author":"Li","year":"2020","journal-title":"Int J Mol Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s43032-025-01789-8","article-title":"Polycystic ovarian syndrome: a review of multi-omics analyses","volume":"32","author":"Naqvi","year":"2025","journal-title":"Reprod Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-12-0718","article-title":"Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome","volume":"168","author":"Galazis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e1987","DOI":"10.1210\/clinem\/dgab931","article-title":"Novel Lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome","volume":"107","author":"Mousa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1210\/jc.2016-2692","article-title":"Discovery of novel lipid profiles in PCOS: do insulin and androgen oppositely regulate bioactive lipid production?","volume":"102","author":"Li","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11306-014-0726-y","article-title":"Lipidomic analysis of plasma samples from women with polycystic ovary syndrome","volume":"11","author":"Haoula","year":"2015","journal-title":"Metabolomics"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"6877541","DOI":"10.1155\/2022\/6877541","article-title":"Identification of the metabolomics signature of human follicular fluid from PCOS women with insulin resistance","volume":"2022","author":"Liu","year":"2022","journal-title":"Dis Markers"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120845","article-title":"Profile of bile acid metabolomics in the follicular fluid of PCOS patients","volume":"11","author":"Yang","year":"2021","journal-title":"Meta"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","article-title":"Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients","volume":"185","author":"Liu","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-6331-9_1","article-title":"Sphingomyelin and its role in cellular signaling","volume":"991","author":"Chakraborty","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo6010006","article-title":"Lysophosphatidylinositol Signalling and metabolic diseases","volume":"6","author":"Arifin","year":"2016","journal-title":"Meta"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00015.2017","article-title":"Interorgan metabolic crosstalk in human insulin resistance","volume":"98","author":"Gancheva","year":"2018","journal-title":"Physiol Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e41456","DOI":"10.1371\/journal.pone.0041456","article-title":"Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes","volume":"7","author":"Barber","year":"2012","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MOL.0b013e3283453dbe","article-title":"Lipidomics is providing new insight into the metabolic syndrome and its sequelae","volume":"22","author":"Meikle","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MCO.0b013e32834fb003","article-title":"Lipidomics","volume":"15","author":"Postle","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ctcp.2019.08.002","article-title":"Role of acupuncture in the treatment of insulin resistance: a systematic review and meta-analysis","volume":"37","author":"Wu","year":"2019","journal-title":"Complement Ther Clin Pract"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1642095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:26:36Z","timestamp":1761283596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1642095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":46,"alternative-id":["10.3389\/fmed.2025.1642095"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1642095","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1642095"}}